3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
13
Rectal Neoplasms
4
Neoplasm Metastasis
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Advanced Solid Tumors
2
Stomach Neoplasms
1
Solid Tumor Cancer
1
Sarcoma, Ewing
1
Sarcoma
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Microsatellite-stable Colorectal Cancer
1
Metastatic Gastric Adenocarcinoma
1
Lung Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Craniopharyngioma
1
Colorectal Cancer Metastatic
1
Breast Neoplasms
1
Anal Cancer Metastatic
1
Advanced Microsatellite Stable Colorectal Cancer
1
Adenomatous Polyposis Coli
1
Interventions
Cyclophosphamide
27
fludarabine
19
Dexamethasone
18
pembrolizumab
12
Rituximab
12
Etoposide
11
venetoclax
10
pomalidomide
9
Gemcitabine
9
Lenalidomide
8
fludarabine phosphate
7
daratumumab
7
Bortezomib
7
glofitamab
6
carfilzomib
6
Vincristine
6
obinutuzumab
5
Temozolomide
5
Prednisone
5
Nivolumab
5
Immunotherapy, Adoptive
5
Doxorubicin
5
Cytarabine
5
Cisplatin
5
Calcium Dobesilate
5
selinexor
4
cemiplimab
4
Carboplatin
4
Azacitidine
4
zanubrutinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
trifluridine tipiracil drug combination
×
90 days
×
Clear all
No trials found.